Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MIRACLE Study: Modulating Immune Responses After Consistent Lipid Exposure

NCT07502898 is registered in ClinicalTrials.gov with Wageningen University as lead sponsor.

NCT NCT07502898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07502898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MIRACLE Study: Modulating Immune Responses After Consistent Lipid Exposure
Lead sponsor
Wageningen University
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2026
Completion date
June 5, 2026
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lipid metabolism, postprandial inflammation